In last trading session, TNF Pharmaceuticals Inc (NASDAQ:TNFA) saw 0.32 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price level of $0.48 trading at -$0.01 or -2.62% at ring of the bell on the day assigns it a market valuation of $1.32M. That closing price of TNFA’s stock is at a discount of -670.83% from its 52-week high price of $3.70 and is indicating a premium of 6.25% from its 52-week low price of $0.45.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

Upright in the red during last session for losing -2.62%, in the last five days TNFA remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.48 price level, adding 27.27% to its value on the day. TNF Pharmaceuticals Inc’s shares saw a change of -58.35% in year-to-date performance and have moved -15.62% in past 5-day. TNF Pharmaceuticals Inc (NASDAQ:TNFA) showed a performance of -57.98% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 67.29% during past 5 years.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 13.69 shares of worth $6557.0 or 0.50% of the total outstanding shares. The later fund manager was in possession of 11.34 shares on Dec 31, 2024 , making its stake of worth around $5429.0 in the company or a holder of 0.41% of company’s stock.